Cite
Protalix BioTherapeutics surges 15% premarket; PLX-102 shows positive results
MLA
“Protalix BioTherapeutics Surges 15% Premarket; PLX-102 Shows Positive Results.” Plus Company Updates, 11 May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.624024285&authtype=sso&custid=ns315887.
APA
Protalix BioTherapeutics surges 15% premarket; PLX-102 shows positive results. (2020, May 11). Plus Company Updates.
Chicago
Plus Company Updates. 2020. “Protalix BioTherapeutics Surges 15% Premarket; PLX-102 Shows Positive Results,” May 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.624024285&authtype=sso&custid=ns315887.